Technology | Patient Monitors | May 16, 2018

Itamar Medical Launches SleePath for AFib Patients at Heart Rhythm 2018

e-Health Cardio Sleep Dashboard provides timely insights into patients’ sleep status and compliance with sleep apnea therapy specially design for cardiologists needs

Itamar Medical Launches SleePath for AFib Patients at Heart Rhythm 2018

May 16, 2018 — Itamar Medical Ltd. announced the launch of SleePath, the first integrated e-health sleep apnea care pathway monitoring system to monitor atrial fibrillation (AF) patients’ sleep apnea management status and compliance with continuous positive airway pressure (CPAP) devices on demand.

Effective management of sleep apnea is essential for improving outcomes in patients with AF, a type of irregular heartbeat that affects 6 million individuals in the United States. SleePath was unveiled at Heart Rhythm 2018, the annual meeting of the Heart Rhythm Society, May 9-12 in Boston.

Sleep apnea occurs in roughly 50 percent of patients with AF; it is found in a higher proportion of AF patients scheduled for catheter ablation, a minimally invasive procedure commonly used to treat AF, which eliminates the cells that give rise to irregular heartbeat. In AF patients with sleep apnea, catheter ablation is most effective when used in conjunction with adherence to a CPAP regimen.

“Effective management of sleep apnea is now believed to be critical for controlling atrial fibrillation post-ablation. The ability for us, the electrophysiologists, to assess patients’ sleep apnea status and their adherence to CPAP on demand and correlating it to the AF manifestations is a big help,” said Elad Anter, M.D., of Beth Israel Deaconess in Boston. “The information that SleePath provides is important for achieving optimal outcomes following catheter ablation. Knowing that a patient isn’t using their CPAP as prescribed is an important first step in opening a dialog with the sleep experts that can identify obstacles and help improve adherence.”

Utilizing data from the Philips Respironics CPAP machines, SleePath includes a Cardio Sleep Dashboard that allows physicians to track multiple aspects of a patient’s sleep apnea status anytime and anyplace. The system monitors care pathway progress, diagnosis status and results, CPAP compliance, the number of days and hours on CPAP, and residual sleep apnea. Data are presented in a user-friendly visual format that makes it easy to see progress or deviation toward specific treatment goals and changes in metrics over time.

For more information: www.itamar-medical.com


Related Content

News | Atrial Fibrillation

Nov. 18, 2024 — Abbott recently announced new data for the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder to ...

Home November 19, 2024
Home
News | Atrial Fibrillation

Oct. 18, 2024 — The Heart Rhythm Society (HRS) Board of Trustees unanimously approved the formation of Heart Rhythm ...

Home October 21, 2024
Home
News | Atrial Fibrillation

Sept. 11, 2024 — In the first national estimate in two decades, researchers at the University of California-San ...

Home September 11, 2024
Home
News | Atrial Fibrillation

July 24, 2024 — Volta Medical, a health technology company developing artificial intelligence (AI) solutions to assist ...

Home July 24, 2024
Home
News | Atrial Fibrillation

July 8, 2024 — Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF) ...

Home July 08, 2024
Home
News | Atrial Fibrillation

June 12, 2024 — A team of Ochsner Health cardiologists recently published an article in the Journal of the American ...

Home June 12, 2024
Home
News | Atrial Fibrillation

April 18, 2024 — New evidence-based research calls into question the conventional three-month blanking period ...

Home April 18, 2024
Home
News | Atrial Fibrillation

March 28, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 28, 2024
Home
News | Atrial Fibrillation

February 27, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home February 27, 2024
Home
News | Atrial Fibrillation

February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in ...

Home February 06, 2024
Home
Subscribe Now